Literature DB >> 12552049

Sera from Guillain-Barré patients enhance leakage in blood-nerve barrier model.

Takashi Kanda1, Masanaga Yamawaki, Hidehiro Mizusawa.   

Abstract

BACKGROUND: In Guillain-Barré syndrome (GBS), the destruction or malfunction of blood-nerve barrier (BNB) has been considered to be the beginning of the disease process. It is unclear whether sera from patients with GBS can open the BNB, and which component of patient sera is most important in the dysregulation of the BNB.
METHODS: The authors evaluated the effect of sera from patients with GBS on permeability of an in vitro BNB model using bovine endoneurial microvascular endothelial cells (PnMEC) cultured on the luminal side of a collagen-coated culture insert (pore size: 0.4 micro m).
RESULTS: PnMEC monolayers challenged by GBS sera showed significantly lower transendothelial electrical resistance and higher clearance of [carboxyl-(14)C]-inulin with or without complement. Sera with anti-GM1 antibody showed greater loosening of the barrier than others. This effect decreased significantly after incubation with pure GM1 antigen, suggesting the importance of anti-GM1 antibody in BNB dysregulation. Serial analyses of [carboxyl-(14)C]-inulin clearance in four patients disclosed a favorable effect of plasmapheresis in restoring BNB function in some cases.
CONCLUSIONS: The authors found an unfavorable effect of sera from patients with GBS on BNB function, supporting involvement of humoral factors causing BNB derangement in the acute stage. Serial evaluation of permeability change using the authors' in vitro system might be useful for the clinical assessment of BNB derangement in individual patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552049     DOI: 10.1212/01.wnl.0000041494.70178.17

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

Authors:  Evan B Stubbs
Journal:  Exp Neurol       Date:  2020-06-17       Impact factor: 5.330

2.  Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1.

Authors:  T Kanda; Y Numata; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 3.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 4.  Biology of the human blood-nerve barrier in health and disease.

Authors:  Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2020-03-03       Impact factor: 5.330

Review 5.  Barrier function in the peripheral and central nervous system-a review.

Authors:  A K Reinhold; H L Rittner
Journal:  Pflugers Arch       Date:  2016-12-12       Impact factor: 3.657

6.  Fingolimod promotes blood-nerve barrier properties in vitro.

Authors:  Hideaki Nishihara; Toshihiko Maeda; Yasuteru Sano; Maho Ueno; Nana Okamoto; Yukio Takeshita; Fumitaka Shimizu; Michiaki Koga; Takashi Kanda
Journal:  Brain Behav       Date:  2018-03-25       Impact factor: 2.708

7.  Case Report: Delayed Guillain-Barré syndrome following trauma: A case series and manage considerations.

Authors:  Yiliu Zhang; Chuxin Huang; Wei Lu; Qing Hu
Journal:  Front Surg       Date:  2022-08-25

8.  Ursolic acid induces neural regeneration after sciatic nerve injury.

Authors:  Biao Liu; Yan Liu; Guang Yang; Zemin Xu; Jiajun Chen
Journal:  Neural Regen Res       Date:  2013-09-25       Impact factor: 5.135

9.  Fulminant Guillain-Barré Syndrome Post Hemorrhagic Stroke: Two Case Reports.

Authors:  Sameeh Abdulmana; Naif Al-Zahrani; Yahya Sharahely; Shahid Bashir; Talal M Al-Harbi
Journal:  Neurol Int       Date:  2021-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.